Skip to main content
. 2019 Feb;16(2):217–224. doi: 10.1513/AnnalsATS.201803-175OC

Table 1.

Participant characteristics

  Frail Prefrail or Normal
Treatment, n (%)    
 Lung volume reduction therapy 20 (35.1) 428 (51.6)
 Medical therapy 37 (64.9) 401 (48.4)
Age, years median (IQR) 69 (64–71) 67 (63–70)
Male, n (%) 34 (59.6) 529 (59.7)
Race, n (%)    
 White (not Hispanic) 52 (91.2) 785 (94.7)
 African American (not Hispanic) 3 (5.3) 30 (3.6)
 Hispanic 1 (1.8) 4 (0.5)
 Asian or Pacific Islander 0 (0) 8 (1.0)
 Other 1 (1.8) 2 (0.2)
Marital status, n (%)    
 Single, never married 0 (0.0) 25 (3.0)
 Separated 0 (0.0) 15 (1.8)
 Divorced or annulled 8 (14.0) 119 (14.4)
 Widowed 8 (14.0) 132 (15.9)
 Married 41 (71.9) 538 (64.9)
Education, n (%)    
 Did not complete high school 19 (33.3) 153 (18.5)
 Completed high school 11 (19.3) 272 (32.8)
 Some college or post high school 20 (35.1) 280 (33.8)
 Bachelor degree or higher 7 (12.3) 124 (15.0)
Economic status, n (%)    
 <$15,000 10 (17.5) 145 (17.7)
 $15,000–$29,999 24 (42.1) 293 (35.7)
 $30,000–$49,999 14 (24.6) 219 (26.7)
 ≥$50,000 9 (15.8) 163 (19.9)
Questionnaires    
 St. George’s Respiratory Questionnaire composite, median (IQR) 60.3 (52.8–69.1) 48.7 (35.7–60.2)
 SF-36, physical functioning median (IQR) 15 (5–30) 30 (15–50)
 SF-36, physical composite, median (IQR) 25.1 (21.3–31.6) 30.1 (23.9–38.8)
 SF-36, mental composite, median (IQR) 46.0 (37.2–56.3) 57.3 (47.4–61.7)
Pulmonary function testing    
 Forced expiratory volume in 1 s, % predicted, median (IQR) mMRC, median (IQR) 23 (18.5–29.0) 26 (20–34)
4 (3–4) 3 (2–4)
 Total lung capacity, % predicted, median IQR 122 (106–134) 119 (107–130)
Laboratory testing
 Albumin abnormal 1.8% 5.2%
 White blood cell count, median (IQR) 8.5 (6.4–10.1) 8.0 (6.6–9.9)

Definition of abbreviations: IQR = interquartile range; SF-36 = Medical Outcomes Short Form-36; mMRC = modified Medical Research Council.

The data show the number of participants, with percentage in parentheses, unless the medians and IQRs are indicated.